We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

How do Doctors Use Thalidomide for Myeloma?

Mary McMahon
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Doctors can use thalidomide for myeloma as a standalone medication or part of combination therapy to attack the myeloma and attempt to prevent recurrence or spread of the cancer. Myeloma is very difficult to treat, and studies in the 1990s illustrating that it responded to thalidomide were received with much interest in the medical community as a result. The dangers of thalidomide require doctors to tightly control the use of the medication, and patients may need to observe some special precautions while taking it.

Thalidomide was originally introduced to the market for the treatment of women with morning sickness during pregnancy. It was withdrawn several years later when practitioners realized the drug was causing severe birth defects because it interfered with fetal development. Despite a notorious reputation, the drug's potential applications continued to be researched, and it was discovered that thalidomide for myeloma could be beneficial, as the drug restricts bloodflow to the tumor and stimulates immune function, shrinking tumors and helping the body fight the cancer.

Doctors often offer thalidomide for myeloma with a steroid like prednisone. Concerns about blood clots while on this medication have led some care providers to recommend prophylactic treatment for clots, like aspirin therapy, along with careful monitoring of patients for any signs of clotting. In addition to clotting, patients can experience side effects like fatigue, constipation, and dizziness while taking thalidomide for myeloma.

The teratogenic effects of this drug mean that in some regions of the world, patients may be required to take birth control while on it. Patients may also need to register with a regulatory agency, submitting proof that they understand the risks and will take every reasonable precaution to avoid pregnancy. While patients with cancer are often unlikely to become pregnant, when they are on drugs known to cause fetal birth defects, their doctors want to be extremely careful.

Thalidomide for myeloma has been shown to be effective for both early and late treatment. Older patients with myeloma that has not been treated or has not responded well to treatment may benefit from therapy with this drug, along with patients of all ages who have been newly diagnosed. If thalidomide is an option for a patient, a doctor will discuss the medication and the potential risks and benefits. Patients may also want to ask about other treatment options, as myeloma treatment is always improving, and they should be aware that this treatment is still considered experimental in some parts of the world, and insurance companies may not cover it.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Mary McMahon
By Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a The Health Board researcher and writer. Mary has a liberal arts degree from Goddard College and spends her free time reading, cooking, and exploring the great outdoors.

Related Articles

Discussion Comments
Mary McMahon
Mary McMahon

Ever since she began contributing to the site several years ago, Mary has embraced the exciting challenge of being a...

Learn more
The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.